20959 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
Compositions for biological systems and methods for preparing and using the same
#302ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#303Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
#304Single-chain CD137-receptor agonist proteins
#305Method for in vivo expansion of T regulatory cells
#306LYMPHOTOXIN-BETA RECEPTOR-BINDING AGENTS, TARGETING ANTIBODIES, AND USES THEREOF
#307Method for making a prenyl group-substituted tyrosine compound
#308Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#309Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#310Etanercept formulations stabilized with combinations of sugars and polyols
#311Compositions and methods related to engineered erythroid cells comprising IL-15
#312COMPOSITION AND METHOD FOR INDUCING ANTI-INFLAMMATORY RESPONSE
#313Methods of delivering a pseudotyped lentivirus
#314MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#315Chimeric protein
#316Therapeutic use of p75NTR neurotrophin binding protein
#317MODELS, METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY BOWEL DISEASE
#318COMPOSITIONS AND METHODS RELATED TO GRAFT VERSUS HOST DISEASE AND TREATMENTS THEREOF
#319Degradable Microparticles for Protein and Small Molecule Delivery
#320Etanercept formulations stabilized with metal ions
#321Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
#322Lymph node-targeting nanoparticles
#323MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#324Compositions and methods related to engineered erythoid cells comprising 4-1BBL
#325Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof
#326BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF
#327Anti-histone therapy in acute kidney injury
#328Wearable noxipoints stimulating devices
#329COMPOSITIONS AND METHODS FOR SENSITIZING CELLS TO TRAIL-INDUCED APOPTOSIS
#330ADMINSTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS
#331Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#332Etanercept formulations stabilized with xylitol
#333Compositions and methods of using a soluble TNF-alpha receptor modified for increased half-life
#334COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS BY MODULATING PROTEIN TYROSINE PHOSPHATASE 13 (PTPN13)
#335Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#336Use Of Immunomodulatory Effective Kits For The Immunotherapeutic Treatment Of Patients Suffering From Myeloid Leukemias
#337Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
#338Modified polynucleotides for the production of oncology-related proteins and peptides
#339Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#340Methods of inducing responsiveness to anti-angiogenic agent
#341In vivo production of proteins
#342SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#343RANKL-specific agent for treating metastatic disease
#344Methods and compositions related to retinoid receptor-selective pathway
#345Treatment Methods for Rheumatoid Arthritis
#346IMMUNOMODULATORY MATERIALS FOR IMPLANTABLE MEDICAL DEVICES
#347METHOD FOR TREATING CANCER USING TETRADRINE
#348Compositions for stabilizing and delivering proteins
#349Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation
#350Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#351Co-expression plasmid
#352Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
#353Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis
#354Combination
#355Human amniotic fluid preparation having long-term stability
#356Treatment of diseases and conditions caused by increased vascular permeability
#357Mesenchymal Stem Cells Expressing Biomarkers that Predict the Effectiveness of Mesenchymal Stem Cells for Treating Diseases and Disorders
#358Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
#359THERAPEUTIC NANOPARTICLES FOR THE TREATMENT OF NEUROBLASTOMA AND OTHER CANCERS
#360Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#361Compositions and methods for inhibiting the biological activity of soluble biomolecules
#362TREATMENT OF LYSOSOMAL DISORDERS (ANTI-TNF THERAPY)
#363COSMETIC PRODUCT WITH LIPOSOMAL GROWTH FACTORS
#364Composite microneedle array including nanostructures thereon
#365Methods for cancer therapy using mutant light molecules with increased affinity to receptors
#366COMPOSITIONS AND METHODS OF REGULATING BONE RESORPTION
#367Transdermal delivery of high viscosity bioactive agents
#368Pharmaceutical compositions and their use for the treatment of autoimmune disorders
#369Synthesis of (S)-2-acetamido-3-(4-hydroxy-3-(3-methylbut-2-enyl) phenyl) propanoic acid derivatives
#370Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors
#371COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY
#372GITRL fusion proteins comprising a human coronin 1a derived trimerization domain
#373HPV vaccines and methods of use thereof
#374Breast cancer vaccines and methods of use thereof
#375Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
#376MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#377Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide, methods and uses therefor
#378WOUND HEALING COMPOSITION
#379Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#380Modified polynucleotides for the production of secreted proteins
#381COMBINATION OF ROCAGLAMIDE AND APOPTOSIS INDUCING SUBSTANCES FOR THE TREATMENT OF CANCER
#382METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA
#383COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS AND METHODS OF USE THEREOF
#384Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#385Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy
#386METHODS AND COMPOSITIONS FOR TREATING CANCER
#387METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS
#388Method of immunotherapy for treatment of human papillomavirus infection
#389Methods for treating cancer
#390Method for the treatment of an autoimmune disease with an agent comprising CTRP3
#391Methods of administering an N-terminal modified PEG-TRAIL
#392Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasias
#393Compositions and methods for promoting the mineralization of biological tissue
#394ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS
#395Methods and constructs for compound delivery
#396HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
#397In vivo individualized systemic immunotherapeutic method and device
#398Compositions, systems and methods for gene expression noise drug screening and uses thereof
#399Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
#400Method of treating cancer
#401Methods for treating or preventing fatty liver disease using CTRP3
#402Use of osteoprotegerin (OPG) to increase human pancreatic beta cell survival and proliferation
#403Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#404Methods of treating biofilm infections comprising administering inhibitors of myeloid-derived suppressor cells
#405Modified polynucleotides for the production of proteins
#406Method of treating intracellular infection
#407Pharmaceutical Composition Comprising a Cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
#408Method for producing autologous proteins
#409Oncolytic vaccinia virus cancer therapy
#410Compositions and methods for inhibiting the biological activity of soluble biomolecules
#411Methods of inducing responsiveness to anti-angiogenic agent
#412Activated leukocyte conditioned supernatant and uses for wound healing
#413Lyophilisate containing a cyclic peptide of formula X-GQRETPEGAEAKPWY-X
#414Immunoconjugates for the treatment of tumours
#415Bruton's tyrosine kinase inhibitor combinations and uses thereof
#416Trail receptor agonists for treatment of fibrotic disease
#417Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light
#418In vivo production of proteins
#419Modified polynucleotides for the production of secreted proteins
#420Anti-histone therapy for vascular necrosis in severe glomerulonephritis
#421Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
#422Composition comprising a TNFR agonist and at least one thioredoxin inhibitor for use in the treatment of carcinoma
#423T cell balance gene expression, compositions of matters and methods of use thereof
#424Method of inducing senescence in tumor cells by administrating TNF-a in combination with IFNa or IFNy
#425Delphinidin for combating melanoma cells
#426Method for production of anti-tumor TRAIL protein
#427Delphinidin for combating melanoma cells
#428Compositions for inducing or suppressing an immune response
#429COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)
#430COMPOSITIONS AND METHODS FOR INCREASING PROTEIN HALF-LIFE
#431METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#432Solvent/polymer solutions as suspension vehicles
#433Antibody-light fusion products for cancer therapeutics
#434Method for treating osteoarthritis using dominant negative tissue necrosis factor
#435Methods and compositions related to a retinoid receptor-selective pathway
#436Immunomodulating compositions and uses therefor
#437MODULATING TRANSENDOTHELIAL MIGRATION AND RECRUITMENT OF GRANULOCYTES BY MODULATING C-MET PATHWAY
#438Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
#439Methods of treating neurological diseases
#440METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2, AND IL2 IN PATIENTS
#441Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure
#442Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
#443HUMAN FUSION PROTEINS COMPRISING SINGLE CHAIN TNFALPHA AND TARGETING DOMAINS
#444Method of stimulating an immune response using a pseudotyped lentivirus
#445Compositions containing HC-HA/PTX3 complexes and methods of use thereof
#446Modified polynucleotides for the production of cosmetic proteins and peptides
#447Methods of and devices for chemical and threshold-gated electrical neuro-immuno-stimulation that triggers the stem cell growth to restore bodily functions
#448Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases
#449Human Bone-Forming Cells in the Treatment of Conditions and Bone Diseases Associated with Immunodeficiency or Immunosuppression
#450Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
#451Methods for inducing migration by dendritic cells and an immune response
#452METHODS OF TREATING OBESITY
#453Methods and compositions for oral administration of protein and peptide therapeutic agents
#454NOVEL SURFACE MARKERS FOR ADIPOSE TISSUE
#455Zinc chelating agents for depleting XIAP and sensitizing tumor cells to apoptosis
#456METHOD OF GENERATING HUMAN MONOCLONAL ANTIBODIES
#457Materials and methods useful for affecting tumor cell growth, migration and invasion
#458Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
#459Systems, compositions, and methods for transplantation and treating conditions
#460Bioactive compositions and methods for their preparation and use
#461MODULATION OF OSTEOCLAST DIFFERENTIATION
#462Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same
#463Treatment methods for rheumatoid arthritis
#464Method of treating bone disorders using TSG-6
#465DR5 RECEPTOR AGONIST COMBINATIONS
#466Embryo implantation
#467Peptides for inhibiting tumor growth
#468Compositions and methods for promoting bone formation
#469Therapeutic use of p75NTR neurotrophin binding protein
#470TARGETED VECTORS FOR CANCER IMMUNOTHERAPY
#471Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12
#472Nanotherapeutic Colloidal Metal Compositions and Methods
#473Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#474VECTOR SIMULTANEOUSLY EXPRESSING DODECAMERIC TRAIL AND HSV-TK SUICIDE GENES, AND ANTICANCER STEM CELL THERAPEUTIC AGENT USING SAME
#475Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors
#476COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS
#477Vaccine immunotherapy for treating cervical cancer in immune suppressed patients
#478Vaccine immunotherapy for treating lymphoma in immune suppressed patients
#479Use of tumor Fas expression to determine response to anti-cancer therapy
#480IMMUNOGENIC EPITOPES OF NGEP ANTIGEN
#481Methods for making cytokine compositions from tissues using non-centrifugal methods
#482Methods for making cytokine compositions from tissues using non-centrifugal methods
#483Acellular compositions for treating inflammatory disorders
#484Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#485Compositions and methods related to graft versus host disease and treatments thereof
#486Stem cell administration to reduce TNF-α level in CSF of an autism spectrum disorder or pervasive development disorder patient
#487Fast-setting alkoxysilane spray foams
#488Regulation of energy metabolism and obesity by modulating a proliferation-inducing ligand (APRIL) or APRIL signaling
#489Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#490Immunocytokine combination therapy
#491Therapeutic TRAIL fusion protein and preparation and use thereof
#492Compositions derived from stem cell released molecules and methods for formulation thereof
#493ADJUVANT COMPOSITIONS WITH 4-1BBL
#494Compositions comprising a Brd4 antagonist and methods for the treatment of HIV
#495Methods and compositions for treating autoimmune diseases
#496Methods and compositions for liquidation of tumors
#497REGULATION OF ENERGY METABOLISM AND OBESITY BY MODULATING B CELL ACTIVATING FACTOR (BAFF, BLYS) OR BAFF SIGNALING
#498Method for attenuating immune response using mesenchymal stem cells and cytokines
#499Method of treating diabetes by a CTRP12 polypeptide
#500Treatment of extracellular matrix to reduce inflammation
#501Cell capable of expressing exogenous GITR ligand
#502Engineered TAA antibody-TNFSF member ligand fusion molecules
#503METHODS FOR PANCREATIC TISSUE REGENERATION
#504Suppression of bone loss by introducing FoxP3+ CD8 T-cells (Tc)
#505Immunomodulatory materials for implantable medical devices
#506Methods for Improving Fracture Healing and Bone Formation
#507CELLULAR THERAPEUTIC APPROACHES TO TRAUMATIC BRAIN AND SPINAL CORD INJURY
#508P2X: inhibition of epithelial cancers and papillomas
#509Vaccine immunotherapy
#510Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients
#511VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#512Composition Containing Trail for Prevention or Treatment of Metabolic Diseases
#513Dimeric Smac Mimetics
#514METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY
#515Medical treatment composition comprising mammalian dental pulp stem cells
#516ONCOLYTIC ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO
#517Kexin-derived vaccines to prevent or treat fungal infections
#518Conjugates for the treatment of mesothelioma
#519Medical treatment composition comprising mammalian dental pulp stem cells
#520USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS
#521Tumor targeted TNF-related apoptosis inducing ligand fusion polypeptide and nucleic acids encoding the same
#522Targeting metabolic enzymes in human cancer
#523Activators of SGK-1 for Use as Cardioprotective Agents
#524Use of a DNA expression construct
#525Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
#526Moesin modulators and uses thereof
#527Composition comprising a peptide and an inhibitor of viral neuraminidase
#528Hyaluronic acid-protein conjugates and method for preparing same
#529VEGF-activated trail ligands
#530Anticancer fusion protein comprising TRAIL and interferon
#531Use of osteoprotegerin (OPG) to increase human pancreatic beta cell survival and proliferation
#532Compositions and methods for inducing migration by dendritic cells and an immune response
#533Vaccine immunotherapy
#534Multi-compartmental macrophage delivery
#535COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#536Activated leukocyte conditioned supernatant and uses for wound healing
#537Sequential administration of a replication defective adenovirus vector in vaccination protocols
#538Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof
#539Methods and compositions for delivering interleukin-1 receptor antagonist
#540Method of treating diabetes-related impaired wound healing
#541Immunobinders directed against sclerostin
#542Composite microneedle array including nanostructures thereon
#543Anticancer fusion protein comprising trail
#544Injection molded microneedle array and method for forming the microneedle array
#545B-cell stimulating fusion proteins of an antigen with BAFF or APRIL
#546Composition for Enhancing Bone Formation
#547Etanercept formulations stabilized with amino acids
#548Method for permeabilizing tumor vasculature using a tumor vasculature permeabilizing molecule to improve access of a therapeutic or diagnostic agent to a tumor
#549Organic compound for the regulation of vectorial ion channels
#550Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
#551Pyrimidinyl indole compounds
#552Kexin-Derived Vaccines to Prevent or Treat Fungal Infections
#553METHODS FOR TREATMENT OF MICROBIAL DISORDERS
#554Solvent/polymer solutions as suspension vehicles
#555Solvent/polymer solutions as suspension vehicles
#556METHOD AND SYSTEM TO REMOVE SOLUBLE TNFR1, TNFR2 AND IL2 IN PATIENTS
#557Antibody-light fusion products for cancer therapeutics
#558Treatment of extracellular matrix to reduce inflammation
#559Oncolytic vaccinia virus cancer therapy
#560Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling
#561Solvent/polymer solutions as suspension vehicles
#562Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
#563Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#564Materials and methods useful for affecting tumor cell growth, migration and invasion
#565Methods and compositions for modulating adipocyte function
#566Method of immunotherapy for treament of human papillomavirus infection
#567Modulation of osteoclast differentiation
#568Agent and methods for reducing inflammatory markers
#569Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders
#570Methods and compositions for treating autoimmune diseases
#571THERAPEUTIC REGIMEN FOR TREATING CANCER
#572Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma
#573Method for treating an intervertebral disc disorder by administering a dominant negative tumor necrosis factor antagonist
#574METABOLICALLY ACTIVATED RECOMBINANT VIRAL VECTORS AND METHODS FOR THEIR PREPARATION AND USE
#575Influenza prevention and treatment composition
#576COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS
#577STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF
#578METHODS OF TREATING PSORIASIS
#579Method for in vivo expansion of T regulatory cells
#580Colloidal metal compositions and methods
#581TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES
#582Compositions and methods for modulating an immune response
#583Targeted gene delivery to dendritic cells
#584Vaccine immunotherapy
#585Immunogenic epitopes of NGEP antigen
#586METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#587Method of treating rheumatoid arthritis with an anti-IL-6R antibody
#588METHODS AND COMPOSITIONS FOR ISLET CELL PRESERVATION
#589METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#590Antibody therapy
#591METHODS FOR PANCREATIC TISSUE REGENERATION
#592METHOD FOR THE ADMINISTRATION OF LIGANDS, AGONISTS OF LIGANDS OF THE TNF FAMILY WITH REDUCED TOXICITY
#593Method for Preventing and Treating Hyperpermeability
#594Composition for Accelerating Nerve Repair
#595Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activators
#596Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
#597Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
#598CATABOLIC AGENTS
#599Human tumor necrosis factor-α mutants
#600METHODS FOR TREATMENT OF MICROBIAL DISORDERS